Scholarly Index
Danette L. Daniels
Foghorn Therapeutics (United States); 6,978 total citations; 78 total publications; best world rank #317
Foghorn Therapeutics (United States)
6,978Total citations
78Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Protein Degradation and Inhibitors | Lifetime | 540 | US 269 | 96.17 |
| Protein Degradation and Inhibitors | 2021-2025 | 340 | US 161 | 93.11 |
| Ubiquitin and proteasome pathways | 2021-2025 | 317 | US 82 | 90.18 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 460 | US 141 | 84.10 |